Charis E. Teh
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
- Immunology 23
- Immune Cell Function and Interaction 17
- T-cell and B-cell Immunology 12
- Immunotherapy and Immune Responses 7
- Genetics 10
- Chronic Lymphocytic Leukemia Research 10
- Diabetes and associated disorders 3
- Co-authors
- Daniel H.D. Gray (20 shared papers)Christopher Carl Goodnow (7 shared papers)Stephen R. Daley (4 shared papers)Andrew Warwick Roberts (7 shared papers)David C.S. Huang (6 shared papers)Jianan Gong (5 shared papers)Rachel Thijssen (5 shared papers)Anselm Enders (4 shared papers)
- Journals
- Cell Death and Differentiation (6 papers)Blood (3 papers)The Journal of Immunology (2 papers)Nature Immunology (2 papers)Blood Advances (2 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Charis E. Teh
40 papers receiving 2.0k citations
Charis E. Teh's Hit Papers
Peers
Comparison fields: 5 of 95
- Immunology 889
- Genetics 434
- Oncology 586
- Hematology 237
- Pathology and Forensic Medicine 307
Countries citing papers authored by Charis E. Teh
This map shows the geographic impact of Charis E. Teh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charis E. Teh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charis E. Teh more than expected).
Fields of papers citing papers by Charis E. Teh
This network shows the impact of papers produced by Charis E. Teh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charis E. Teh. The network helps show where Charis E. Teh may publish in the future.
Co-authors
The 25 scholars most cited alongside Charis E. Teh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia Hit paper breakdown → | 2018 | 346 |
| 2 | 2016 | 310 | |
| 3 | 2018 | 167 | |
| 4 | 2019 | 120 | |
| 5 | 2011 | 114 | |
| 6 | 2009 | 92 | |
| 7 | 2022 | 74 | |
| 8 | 2012 | 73 | |
| 9 | 2017 | 61 | |
| 10 | 2011 | 58 | |
| 11 | 2016 | 57 | |
| 12 | 2023 | 57 | |
| 13 | 2016 | 52 | |
| 14 | 2017 | 45 | |
| 15 | 2010 | 44 | |
| 16 | 2018 | 43 | |
| 17 | 2012 | 41 | |
| 18 | 2020 | 29 | |
| 19 | 2020 | 29 | |
| 20 | 2020 | 26 |
About Charis E. Teh
Charis E. Teh is a scholar working on Immunology, Genetics, Hematology, Oncology and Pathology and Forensic Medicine, having authored 40 papers that have together received 2.0k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (17 papers), T-cell and B-cell Immunology (12 papers), Chronic Lymphocytic Leukemia Research (10 papers), Immunotherapy and Immune Responses (7 papers), Cancer Genomics and Diagnostics (3 papers), CAR-T cell therapy research (3 papers), Diabetes and associated disorders (3 papers) and Cell death mechanisms and regulation (3 papers). The work is most often cited by research in Immunology (889 citations), Genetics (434 citations), Oncology (586 citations), Hematology (237 citations) and Pathology and Forensic Medicine (307 citations). Charis E. Teh has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Daniel H.D. Gray, Christopher Carl Goodnow, Stephen R. Daley, Andrew Warwick Roberts, David C.S. Huang, Jianan Gong, Rachel Thijssen, Anselm Enders, Mary Ann Anderson and Richard W. Birkinshaw. Their work appears in journals such as Cell Death and Differentiation, Blood, The Journal of Immunology, Nature Immunology and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.